CVS - Hot Stocks: NVDA drops on preliminary results; MNDY TGTX rally; SGFY climbs on takeover report

Nvidia ( NASDAQ: NVDA ) drew significant attention during Monday's midday trading. The semiconductor bellwether dropped after reporting disappointing preliminary results.

Elsewhere, earnings-related news had the opposite impact on monday.com ( MNDY ). The stock rallied on the back of Street-beating financial figures.

TG Therapeutics ( TGTX ) saw midday gains as well, fueled by quarterly results and hope for regulatory approval for the firm's MS drug. Meanwhile, Signify Health ( SGFY ) jumped on reports of takeover interest from CVS ( CVS ).

Gainers

A strong earnings report prompted buying in monday.com ( MNDY ). Shares jumped nearly 19% after releasing a narrower-than-expected Q2 loss .

The maker of work management software reported revenue that rose 75% from last year. The company also gave an upbeat forecast, saying it projects a top-line total between $130M and $131M. Analysts were targeting $126M.

TG Therapeutics ( TGTX ) also showed strength in the wake of its quarterly update . Shares soared 17% in midday trading.

The company topped expectations with a narrower Q2 loss. TGTX added that the rest of its fiscal year will be focused on gaining regulatory approval for ublituximab, a potential treatment for relapsing forms of multiple sclerosis. A decision from the U.S. Food and Drug Administration is targeted for late December.

Signify Health ( SGFY ) represented another major intraday gainer. Shares jumped almost 16% after the Wall Street Journal reported that CVS Health ( CVS ) is interested in purchasing the home healthcare company.

Decliner

Nvidia ( NVDA ) dropped almost 9% after the semiconductor company revealed weak preliminary Q2 results . The company said it will report a revenue figure of $6.7B, a decline of 19% from last year and below the $8.1B that analysts were predicting.

NVDA pointed to weakness in its gaming business for the shortfall. The company said this division brought in $2.04B in Q2, down 33% from the previous year.

To keep up with Wall Street's best- and worst-performing stocks throughout the session, turn to Seeking Alpha's On The Move section .

For further details see: